Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Artificial Intelligence (AI) Pathology Quality Control Market Size, Value And Growth Trends Through 2030

The artificial intelligence (AI) pathology quality control market has experienced remarkable expansion, projected to increase from $1.78 billion in 2025 to $2.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 21.4%. Factors contributing to this upward trajectory during the preceding period included a rising volume of pathology tests, the progressive digitization of pathology slides, the escalating intricacy of cancer diagnoses, a need for uniform reporting standards, and the nascent integration of AI-powered pathology solutions.

The artificial intelligence (AI) pathology quality control sector is projected to experience substantial expansion in the upcoming years, reaching an estimated value of $4.65 billion by 2030, driven by a compound annual growth rate of 21.1%. This projected increase is fueled by several key factors, including heightened investment in digital pathology systems, escalating demand for precise diagnostic solutions, the broader incorporation of AI validation into clinical processes, and the increasing utilization of pathology data analytics, alongside a growing regulatory focus on ensuring high-quality diagnostics. During this forecast period, significant trends are expected to emerge, such as the increased implementation of AI for assessing slide quality, a greater uptake of tools designed for automated error detection, a push towards standardizing pathology workflows, the further integration of digital pathology, and a more pronounced emphasis on guaranteeing the accuracy of diagnoses.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28124&type=smp

Artificial Intelligence (AI) Pathology Quality Control Market Demand Drivers: What Is Fueling Industry Growth?

A surge in the need for individualized medical care is anticipated to fuel the expansion of the artificial intelligence (AI) pathology quality control sector. Personalized medicine, which involves customizing medical interventions and preventative measures based on an individual’s distinct genetic profile, daily habits, and surroundings, is seeing greater use due to breakthroughs in genomics. These advancements allow for the exact pinpointing of genetic differences and the development of treatments specifically suited to each person. AI pathology quality control contributes significantly by offering accurate and dependable diagnostic information, thereby facilitating the creation of customized therapeutic plans. It helps to minimize mistakes in diagnosis through automated quality assessments, boosting both precision and trustworthiness, and ultimately improving patient-tailored healthcare. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medications in 2023, a notable rise compared to the 12 approvals granted in 2022. Consequently, the growing requirement for personalized medicine is expected to be a key factor in the advancement of the artificial intelligence (AI) pathology quality control market.

Artificial Intelligence (AI) Pathology Quality Control Market Segmentation: How Is The Market Structured Across Key Categories?

The artificial intelligence (AI) pathology quality control market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software

2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment

3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services

Artificial Intelligence (AI) Pathology Quality Control Market Innovation Trends: Which Developments Are Transforming The Industry?

Within the realm of artificial intelligence in pathology quality control, key industry players are concentrating their efforts on forging sophisticated technological offerings. These innovations aim to elevate diagnostic precision, optimize laboratory operational flows, and uphold the trustworthiness of pathological information. Such cutting-edge AI-driven tools represent the forefront of technological advancement, leveraging artificial intelligence to accomplish intricate assignments with superior levels of precision, rapidity, and operational effectiveness. Illustratively, a significant development occurred in November 2023 when PathAI, a biotechnology firm headquartered in the United States, unveiled Artifact Detect 1 integrated into its AISight digital pathology system. This specific functionality automates the identification and measurement of artifacts found in whole slide images (WSIs). Artifacts are essentially irrelevant morphological characteristics that have the potential to undermine the accuracy of diagnoses. By automatically performing an initial quality assessment of slides for potential issues, ArtifactDetect serves to reduce instances of incorrect diagnoses and the necessity for repeat scans, thereby bolstering accuracy, improving laboratory operational efficiency, and increasing overall output. This technological advancement facilitates prompt remedial measures, such as re-staining or re-scanning processes, which ultimately refine the digital workflow and preserve valuable resources for both laboratory technicians and pathologists.

Artificial Intelligence (AI) Pathology Quality Control Market Competitive Landscape And Leading Companies

Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., Gestalt Diagnostics LLC

Access The Complete Artificial Intelligence (AI) Pathology Quality Control Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-pathology-quality-control-global-market-report

Artificial Intelligence (AI) Pathology Quality Control Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the artificial intelligence (AI) pathology quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) pathology quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model